Trials / Completed
CompletedNCT04214652
Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, tolerability, and efficacy of IDP-126 Gel in comparison IDP-126 Vehicle Gel at Weeks 2, 4, 8, and 12.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-126 Gel | IDP-126 Gel applied topically to the face once daily for 12 weeks. |
| DRUG | IDP-126 Vehicle Gel | IDP-126 Vehicle Gel applied topically to the face once daily for 12 weeks. |
Timeline
- Start date
- 2020-01-27
- Primary completion
- 2021-03-18
- Completion
- 2021-03-18
- First posted
- 2020-01-02
- Last updated
- 2024-02-01
- Results posted
- 2024-02-01
Locations
13 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04214652. Inclusion in this directory is not an endorsement.